http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109369772-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J73-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D221-18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J73-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2018-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109369772-B |
| titleOfInvention | Synthetic method and anti-tumor application of phenanthridine nitidine derivatives |
| abstract | The invention belongs to the technical field of organic synthetic chemistry, relates to the field of nitidine drugs, and particularly provides a synthetic method and anti-tumor application of a phenanthridine nitidine derivative. Experiments prove that the phenanthridine nitidine derivatives have good anti-tumor activity, have obvious inhibition effect on HepG2, A549, H460 and CNE1 cancer cell strains, and can be used for research on preparation of anti-tumor drugs. In addition, the preparation method has the advantages of mild reaction conditions, high conversion rate and wide substrate universality. |
| priorityDate | 2018-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.